Cho, Christina http://orcid.org/0000-0002-7964-3011
Devlin, Sean
Maloy, Molly
Horowitz, Mary M.
Logan, Brent
Rizzo, J. Douglas http://orcid.org/0000-0003-1474-1152
Giralt, Sergio A. http://orcid.org/0000-0003-1944-5053
Perales, Miguel-Angel http://orcid.org/0000-0002-5910-4571
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P01 CA23766, P30 CA008748, P01 CA23766, P30 CA008748, P01 CA23766, P30 CA008748, P01 CA23766, P30 CA008748, P01 CA23766, P30 CA008748, P01 CA23766, P30 CA008748)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 12 June 2023
Revised: 20 June 2023
Accepted: 30 June 2023
First Online: 8 July 2023
Competing interests
: CC, SD, MM, MMH, BL: None. JDR: Optum Stem Cell - Compensation as participant on expert panel to provide input/information about the center-specific survival analysis; compensation directed to Medical College of Wisconsin rather than personally. SAG: Amgen, Actinium, BMS, Celgene, GSK, Kite, Janssen, Jazz Pharma, Johnson & Johnson, Novartis, Pfizer, Sanofi, Spectrum Pharma, Takeda - Membership on board of directors or advisory committees. Amgen, Actinium, Celgene, Johnson & Johnson, Miltenyi, Omeros - Institutional research support. M-AP—Adicet, Allovir, Caribou Biosciences, Celgene, Bristol-Myers Squibb, Equilium, Exevir, Incyte, Karyopharm, Kite/Gilead, Merck, Miltenyi Biotec, MorphoSys, Nektar Therapeutics, Novartis, Omeros, OrcaBio, Syncopation, VectivBio AG, Vor Biopharma - Honoraria. Cidara Therapeutics, Medigene, Sellas Life Sciences - DSMB. NexImmune - Membership on advisory committee. NexImmune, Omeros, OrcaBio - Ownership interests. Other. Incyte, Kite/Gilead, Miltenyi Biotec, Nektar Therapeutics, Novartis - Institutional research support.